期刊文献+

ACEI在心力衰竭治疗中的应用 被引量:4

Application of ACEI in the treatment of heart failure
原文传递
导出
摘要 本文简述血管紧张素转化酶抑制药(angiotensin converting enzyme inhibitor,ACEI)的发展、药理和生理作用及治疗心力衰竭的循证医学依据,同时讨论ACEI的不良反应。 The development of angiotensin converting enzyme inhibitors (ACEI), their pharmacological and physiological action also the side effects, and clinical trial data of medicine evidence were discussed in this article.
出处 《临床药物治疗杂志》 2012年第4期5-8,12,共5页 Clinical Medication Journal
  • 相关文献

参考文献17

  • 1Sica DA. Pharmacotherapy in congestive heart failure: Angiotensin- converting enzyme inhibitors and angiotensin receptor blockers in congestive heart failure.: do they differ in their renal effects in man [ J ] . Congest Heart Fail, 2001, 7:156-161.
  • 2Weintraub WS, Cole J, Tooley JF. Cost and cost-effectiveness studies in heart failure research [ J ] . Am Heart J, 2002, 143:565-576.
  • 3Diekstein K, Kjekshus J, OPTIMAAL Steering Committee of the OPTIMAAL Study Group. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomized trim [ J ] . Lancet, 2002, 360:752-760.
  • 4Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [ J ] . N Engl J Med, 2003, 349:1893-1906.
  • 5Squire IB, O' Kane KP, Anderson N, et al. Bradykinin B(2) receptor antagonism attenuates the blood pressure response to acute ACE inhibition in normal man [ J ] . Hypertension, 2000, 36:132-136.
  • 6MeAlister FA, Stewart S, Ferrua S, et al. Multidiseiplinary strategies for the management of heart failure patients at high risk of admission:a systematic review of randomized trials [ J ] . J Am coil Cardiol, 2004, 44:810-819.
  • 7Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction; systematic overview of individual data from 100 000 patients in randomized trial. ACE Inhibitor Myocardial Infarction Collaborative Group [ J ] . Circulation, 1998, 97:2202-2212.
  • 8Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventrieular dysfunetion:a systematic overview of data from individual patients [ J ] . Lancet, 2000, 355:1575-1581.
  • 9Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [ J ] . Eur Heart J, 2008, 29:2388-2442.
  • 10Levy PD, Nandyal D, Welch RD, et al. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-eonverting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life- Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE- HF) [ J ] . Am Heart J, 2010, 159:222-230.

同被引文献34

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部